Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
643 |
|
| Actual shortage: | 17 (3%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 85 (13%) | |
| Resolved: | 541 (84%) | |
Discontinuation Reports |
233 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 233 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
80 (9%) |
|
Overdue reports |
1 (6%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-NIFEDIPINE EXTENDED RELEASE | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-01-29 | 2020-06-10 | 104685 |
| MYLAN-NIFEDIPINE EXTENDED RELEASE | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-01-29 | 2020-06-10 | 104688 |
| MOVISSE | 0.35MG | TABLET | Resolved | 2020-01-29 | 2020-02-26 | 104691 |
| MYLAN-BUDESONIDE AQ | 100MCG | SPRAY, METERED DOSE | Resolved | 2020-02-04 | 2020-03-04 | 105234 |
| MYLAN-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2020-02-04 | 2021-05-17 | 105239 |
| FREYA 28 | 0.15MG 0.03MG | TABLET | Resolved | 2020-02-12 | 2020-03-04 | 105774 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Resolved | 2020-02-12 | 2020-04-02 | 105793 |
| CLARUS | 40MG | CAPSULE | Resolved | 2020-03-18 | 2020-04-08 | 108871 |
| MOVISSE | 0.35MG | TABLET | Resolved | 2020-03-25 | 2020-04-29 | 109369 |
| MYLAN-ACYCLOVIR | 400MG | TABLET | Resolved | 2020-04-02 | 2020-04-29 | 110411 |
| MYLAN-ATORVASTATIN | 80MG | TABLET | Resolved | 2020-04-02 | 2020-05-26 | 110438 |
| MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-04-02 | 2020-07-01 | 110465 |
| MYLAN-GALANTAMINE ER | 16MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-04-02 | 2020-05-12 | 110472 |
| MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2020-04-02 | 2020-06-17 | 110480 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Resolved | 2020-04-02 | 2020-05-06 | 110497 |
| MYLAN-PROPAFENONE | 300MG | TABLET | Resolved | 2020-04-02 | 2020-04-29 | 110504 |
| MYLAN-VERAPAMIL SR | 120MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-04-02 | 2021-03-09 | 110509 |
| MYLAN-LAMOTRIGINE | 25MG | TABLET | Resolved | 2020-04-07 | 2020-05-06 | 111260 |
| MYLAN-CINACALCET | 60MG | TABLET | Resolved | 2020-04-07 | 2020-07-10 | 111282 |
| MYLAN-ESOMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2020-04-22 | 2021-05-17 | 112771 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-RISPERIDONE ODT | 0.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149759 |
| MYLAN-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149762 |
| MYLAN-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149765 |
| MYLAN-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149768 |
| MYLAN-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149771 |
| TOBRAMYCIN INJECTION, USP | 40MG | SOLUTION | Discontinued | 2022-01-12 | 2022-01-12 | 152485 |
| MYLAN-TOLTERODINE ER | 2MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155037 |
| MYLAN-TOLTERODINE ER | 4MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155040 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160318 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160323 |
| MYLAN-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167806 |
| MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167819 |
| MYLAN-VERAPAMIL | 80MG | TABLET | Discontinued | 2024-04-11 | 2024-04-12 | 224846 |